| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Genetics, Albert Einstein College of Medicine, Bronx 10461 [O. P. D., S. S.], and the Population Council, Rockefeller University, New York, New York 10021 [D. M. P.]
The mouse L-cell derivative A9, deficient in hypoxanthine phosphoribosyltransferase and previously shown to be highly tumorigenic in nude mice, was infected deliberately with known mycoplasma species and transplanted in nude mice in order to determine the effect of the adventitious organisms on tumor initiation and growth rate. Two of the most common mycoplasma strains found in contaminated cell cultures, Mycoplasma hyorhinis and Acholeplasma laidlawii, have been used, since both of these possess high levels of endogenous hypoxanthine phosphoribosyltransferase activity that can be utilized as a quantitative measure of cell contamination. The presence of mycoplasma particles in the infected cultures was verified independently by electron microscopy and a fluorescent staining technique. The results indicate that contamination of cell lines by mycoplasma can significantly alter the tumor initiation and growth rate of normally tumorigenic cells injected in nude mice. In addition, at least for the 2 mycoplasma strains described here, the passage of contaminated cells in nude mice invariably resulted in their complete elimination from the cultures. Since many animal cell lines are tumorigenic in nude mice, this observation suggests that passaging cell in vivo in nude mice may be a simple and effective means of obtaining mycoplasma-free cells from contaminated cell cultures.
1 Supported by research grants from the National Science Foundation (PCM 76-07573), the NIH (5 R01 GM21014), and a Genetics Center Grant to the Albert Einstein College of Medicine (NIGMS GM19100).
2 Present address: Department of Cell Biology and Genetics, Medical Faculty, Erasmus University, Rotterdam, The Netherlands.
3 Supported by a Faculty Research Award from the American Cancer Society. To whom requests for reprints should be addressed.
Received 3/ 3/77. Accepted 5/18/77.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |